3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
14
Phase NA
1
Phase 1/2
1
Phase 1
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
NET
1
Lymphoid
1
Gastrointestinal
1
Endocrine
1
CNS
1
Conditions
Carcinoma, Non-Small-Cell Lung
368
Neoplasms
324
Neoplasm Metastasis
287
Leukemia, Myeloid, Acute
279
Breast Neoplasms
275
Colorectal Neoplasms
233
Melanoma
197
Ovarian Neoplasms
189
Recurrence
187
Multiple Myeloma
177
Prostatic Neoplasms
156
Pancreatic Neoplasms
156
Lung Neoplasms
156
Squamous Cell Carcinoma of Head and Neck
148
Glioblastoma
145
Lymphoma, Non-Hodgkin
143
Triple Negative Breast Neoplasms
118
Myelodysplastic Syndromes
114
Carcinoma, Renal Cell
111
Stomach Neoplasms
110
Precursor Cell Lymphoblastic Leukemia-Lymphoma
105
Glioma
105
Advanced Solid Tumors
104
Lymphoma
103
Lymphoma, Large B-Cell, Diffuse
102
Brain Neoplasms
102
Lymphoma, B-Cell
98
Carcinoma, Hepatocellular
94
Endometrial Neoplasms
92
Lymphoma, Follicular
90
Interventions
amino-acid, glucose, and electrolyte solution
1
177Lu-octreotide, DOTA(0)-Tyr(3)-
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Neuroectodermal Tumors, Primitive, Peripheral
×
1 year
×
Clear all
NCT06441331
2026-05-01
KinLET
ITM Solucin GmbH
Phase 1
Recruiting
20 enrolled